-
Decluttering Complexity: A Pragmatic Framework for Simplifying Global Health Economic Models for HTA
Sep 9, 2025, 16:22 PM -
Clinical Functional Profile and Neuroimaging in Cerebral Palsy: A Population-Based Study
Sep 9, 2025, 16:22 PM -
Automation-Only Is NOT AI: Beware, HEOR Colleagues
Sep 9, 2025, 16:22 PM -
Integrating Mendelian Randomization With Real-World Evidence: Cost-Effectiveness of Lipoprotein Testing for Primary Prevention of Cardiovascular Disease in High-Income Countries
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Isavuconazole vs. Voriconazole for the Treatment of Invasive Aspergillosis in Morocco
Sep 9, 2025, 16:22 PM -
France and the Challenge of High-Cost Innovative Drug Expenditures in Hospitals
Sep 9, 2025, 16:22 PM -
Health Economic Analysis of Risk- and Age-Based Pneumococcal Vaccination With PCV21 vs. PCV20 in France
Sep 9, 2025, 16:22 PM -
Fezolinetant Veoza™ As a Nonhormonal Treatment for Moderate to Severe Vasomotor Symptoms in Postmenopausal Women: A Systematic Literature Review and Meta-Analysis
Sep 9, 2025, 16:22 PM -
The Incidence, Mortality, and Survival of Nonmetastatic Colorectal Cancer (CRC) per TNM Stages in the United States: A Surveillance, Epidemiology, and End Results (SEER) 2018-2022 Database Analysis
Sep 9, 2025, 16:22 PM -
Evolution of Health Technology Assessment (HTA) in India: A Scoping Review and Thematic Analysis
Sep 9, 2025, 16:22 PM -
Early Adoption of New Combination Biologic Therapy Enabled by Enhanced Diagnostic Accuracy in Inflammatory Bowel Disease (IBD) Can Be a Budget-Neutral Approach: A Budget Impact Analysis in Italy
Sep 9, 2025, 16:22 PM -
Impact on Prescribing Choice Following the Identification of Preferred Continuous Glucose Monitoring Sensors in the Irish Healthcare Setting
Sep 9, 2025, 16:22 PM -
Economic Evaluations of Medical Interventions for Adult People Living With Obesity: Protocol for a Systematic Literature Review
Sep 9, 2025, 16:22 PM -
Modeling the Lifetime Effects of Lecanemab in Early Alzheimer’s Disease
Sep 9, 2025, 16:22 PM -
Persistence With Osteoporosis Medication Treatments Among Chinese Patients With Osteoporosis: A Retrospective Cohort Study
Sep 9, 2025, 16:22 PM -
Evaluating the Economic Value of First-Line (1L) Treatment Strategies for Locally Advanced or Metastatic Urothelial Carcinoma (la/mUC): Insights From the Portuguese Healthcare System
Sep 9, 2025, 16:22 PM -
NICE Has Embraced Single-Arm Trials in Technology Appraisals but Where Is the Guidance?
Sep 9, 2025, 16:22 PM -
Real-World Assessment Process to Identify Fit-for-Purpose Data Sources to Meet Milestones for Post-Marketing Requirements (PMR), Post Authorization Safety Studies (PASS), and Health Technology Assessment (HTA) Submissions Utilizing Source Exploration...
Sep 9, 2025, 16:22 PM -
Impact of Resmetirom on Liver Transplant Demand and Outcomes in US Patients With MASH
Sep 9, 2025, 16:22 PM -
Economic and Antibiotic Benefits of Vonoprazan-Based Regimens for First-Line Helicobacter Pylori Eradication in China
Sep 9, 2025, 16:22 PM
